Cytotoxicity by Tumor Necrosis Factor is Linked with the Cell Cycle But Does Not Require DNA Synthesis

References

• Agarwal S., Drysdale E. B., Shin H. S. Tumor necrosis factor‐mediated cytoxicity involves ADP‐ribosylation. J. Immunol 1988; 140: 4187
   PubMed Web of Science ®Google Scholar
• Aggarwal B. B., Eessalu T. E., Hass P. E. Characterization of receptors for human tumor necrosis factor and their regulation by γ‐interferons. Nature 1985; 318: 665
   PubMed Web of Science ®Google Scholar
• Baglioni C., McCandless S., Tavernier J., Fiers W. Binding of human tumor necrosis factor to high affinity receptors on HeLa and lymphoblastoid cells sensitive to growth inhibition. J. Biol. Chem 1985; 260: 13395
   PubMedGoogle Scholar
• Beutler B., Cerami A. Cachectin and tumour necrosis factor as two sides of the same biological coin. Review article. Nature 1986; 320: 584
   PubMed Web of Science ®Google Scholar
• Chen M. ‐J., Holskin B., Strickler J., Gorniak J., Clark M. A., Johnson P. J., Mitcho M., Shalloway D. Induction by E1A oncogene expression of cellular susceptibility to lysis by TNF. Nature 1987; 330: 581
   PubMed Web of Science ®Google Scholar
• Clevenger C. V., Bauer K. D., Epstein A. L. A method for simultaneous nuclear immunofluorescence and DNA content quantitation using monoclonal antibodies and flow cytometry. Cytometry 1985; 6: 208
   PubMedGoogle Scholar
• Coffman F. C., Green L. M., Ware C. F. The relationship of receptor occupancy to the kinetics of cell death mediated by tumor necrosis factor. Lymphokine Res 1988; 7: 371
   Google Scholar
• Coffman F. D., Green L. M., Godwin A., Ware C. F. Cytotoxicity mediated by tumor necrosis factor in variant subclones of the ME‐180 cervical carcinoma line: modulation by specific inhibitors of DNA topoisomerase II. J. Cell. Biochem 1989; 39: 95
   Google Scholar
• Collins J. M. Transient structure of replicative DNA in normal and transformed human fibroblasts. J. Biol. Chem 1979; 254: 10167
   Google Scholar
• Darzynciewicz Z., Williamson B., Carswell E. A., Old L. J. Cell cycle‐specific effects of tumor necrosis factor. Cancer Res 1984; 44: 83
   Google Scholar
• Dealtry G. B., Naylor M. S., Fiers W., Balkwill F. R. DNA fragmentation and cytotoxicity caused by tumor necrosis factor is enhanced by interferon‐γ. Eur. J. Immunol 1987; 17: 689
   PubMed Web of Science ®Google Scholar
• Duke R. C., Chervenak R., Cohen J. J. Endogenous endonucleaste‐induced DNA fragmentation: An early event in cell‐mediated cytolysis. Proc. Natl. Acad. Sci. USA 1983; 80: 6361
   PubMed Web of Science ®Google Scholar
• Fletcher W. H., Shiu W. S., Ishida T. A., Haviland D. H., Ware C. F. Resistance to the cytolytic action of lymphotoxin and tumor necrosis factor coincides with the presence of gap junctions uniting target cells. J. Immunol 1987; 139: 956
   PubMed Web of Science ®Google Scholar
• Green L. M., Reade J. L., Ware C. F. Rapid colorimetric assay for cell viability: Application to the quantitation of cytotoxic and growth inhibitory lymphokines. J. Immunol. Methods 1984; 70: 257
   PubMed Web of Science ®Google Scholar
• Green L. M., Reade J. L., Ware C. F., Devlin P. E., Liang D. M., Devlin J. J. Cytotoxic lymphokines produced by cloned human cytotoxic T lymphocytes. II. A novel CTL‐produced cytotoxin that is antigenically distinct from tumor necrosis factor and alpha lymphotoxin. J. Immunol 1986; 137: 3488
   PubMed Web of Science ®Google Scholar
• Kehrl J. H., Alvarez‐Mon M., Delsing G. A., Fauci A. S. Lymphotoxin is an important T cell‐derived growth factor for human B cells. Science 1987; 238: 1144
   PubMed Web of Science ®Google Scholar
• Koff W. C., Fann A. V. Human tumor necrosis factor‐alpha kills herpes‐virus infected cells but not normal cells. Lymphokine Res. 1986; 5: 215
   Google Scholar
• Lewis G. D., Aggarwal B. B., Eessalu T. E., Sugarman B. J., Shephard H. M. Modulation of the growth of transformed cells by human tumor necrosis factor alpha and interferon gamma. Cancer Res 1987; 47: 5382
   PubMed Web of Science ®Google Scholar
• Matthews N., Neale M. L., Jackson D. K., Stark J. M. Tumor cell killing by tumor necrosis factor: Inhibition by anaerobic conditions, free‐radical scavengers and inhibitors of arachidonate metabolism. Immunology 1987; 62: 153
   PubMed Web of Science ®Google Scholar
• Old L. J. Tumor necrosis factor (TNF). Science 1985; 230: 630
   PubMed Web of Science ®Google Scholar
• Pober J. S., Lapierre L. A., Stolpen A. H., Brock T. A., Springer T. A., Fiers W., Bevilacqua M. P., Mendrick D. L., Gimbrone M. A., Jr. Activation of cultured human endothelial cells by recombinant lymphotoxin: Comparison with tumor necrosis factor and interleukin 1 species. J. Immunol 1987; 138: 3319
   PubMed Web of Science ®Google Scholar
• Russell J. H., Dobos C. B. Mechanisms of immune lysis. II. CTL‐induced nuclear disintegration of the target begins within minutes of cell contact. J. Immunol 1980; 125: 1256
   PubMedGoogle Scholar
• Scheurich P., Thoma B., Ucer U., Pfizenmaier K. Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)‐alpha: Induction of TNF receptors on human T cells and TNF‐alpha‐mediated enhancement of T cell responses. J. Immunol 1987; 138: 1786
   PubMed Web of Science ®Google Scholar
• Schmid D. S., Hornung R., McGrath K. M., Paul N., Ruddle N. H. Target cell DNA fragmentation is mediated by lymphotoxin and tumor necrosis factor. Lymphokine Res 1987; 6: 195
   PubMedGoogle Scholar
• Shalaby M. R., Aggarwal B. B., Rinderknecht E., Svedersky L. P., Finkle B. S., Palladino M. A. Activation of polymorphonuclear neutrophil functions by gamma‐interferon and tumor necrosis factors. J. Immunol 1985; 135: 2069
   PubMed Web of Science ®Google Scholar
• Sugarman B. J., Aggarwal B. B., Hass P. E., Figari I. S., Palladino M. A., Jr., Shephard H. M. Recombinant human tumor necrosis factor‐α: Effects on proliferation of normal and transformed cells, in vitro. Science 1985; 230: 943
   PubMed Web of Science ®Google Scholar
• Terasima T., Tolmach L. J. Growth and nucleic acid synthesis in synchronously dividing populations of HeLa cells. Exp. Cell Res 1963; 30: 344
   PubMed Web of Science ®Google Scholar
• Tomasz M., Lipman R., Chowdary D., Pawlak J., Verdine G. L., Nakanishi K. Isolation and structure of a covalent cross‐link adduct between mitomycin C and DNA. Science 1987; 235: 1204
   PubMed Web of Science ®Google Scholar
• Trinchieri G., Kobayashi M., Rosen M., Louden R., Murphy M., Perussia B. Tumor necrosis factor and lymphotoxin induce differentiation of human myeloid cells in synergy with immune interferon. J. Exp. Med 1986; 164: 206
   Google Scholar
• Tsujimoto M., Feinman R., Kohase M., Vilcek J. Characterization and affinity crosslinking of receptors for tumor necrosis factor on human cells. Arch. Biochem. Biophys 1986; 249: 563
   Google Scholar
• Vilcek J., Palombella V. J., Henriksen‐DeStefano D., Swenson C., Feinman R., Hirai M., Tsujimoto M. Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors. J. Exp. Med 1986; 163: 632
   PubMed Web of Science ®Google Scholar
• Ware C. F., Green L. M. Cytotoxic lymphokines elaborated by effector T cells. Lymphokines 1987; 14: 307
   Google Scholar
• Wong G. H. W., Goeddel D. V. Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science 1988; 242: 941
   PubMed Web of Science ®Google Scholar
• Wong G. H. W., Krowka J., Stites D. P., Goeddel D. V. In vitro anti‐human immunodeficiency virus activities of tumor necrosis factor‐alpha and interferon‐gamma. J. Immunol 1988; 140: 120
   PubMed Web of Science ®Google Scholar